Your browser doesn't support javascript.
loading
Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy Dataset.
Nakane, Sayuri; Tanaka-Mizuno, Sachiko; Nishiyama, Chika; Kochi, Kenji; Yamamoto-Sasaki, Madoka; Takeuchi, Masato; Ogawa, Yusuke; Doi, Yuko; Arai, Masaru; Fujii, Yosuke; Matsunaga, Toshiyuki; Furukawa, Toshiaki A; Kawakami, Koji.
Affiliation
  • Nakane S; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Tanaka-Mizuno S; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Nishiyama C; Department of Digital Health and Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.
  • Kochi K; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Yamamoto-Sasaki M; Department of Critical Care Nursing, Kyoto University Graduate School of Human Health Science, Kyoto, Japan.
  • Takeuchi M; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Ogawa Y; Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd, Tokyo, Japan.
  • Doi Y; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Arai M; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Fujii Y; Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsunaga T; Ain Holdings Inc, Sapporo, Hokkaido, Japan.
  • Furukawa TA; Kraft Inc, Chiyoda, Tokyo, Japan.
  • Kawakami K; Ain Holdings Inc, Sapporo, Hokkaido, Japan.
Child Psychiatry Hum Dev ; 54(5): 1250-1257, 2023 10.
Article in En | MEDLINE | ID: mdl-35201525
ABSTRACT
Little is known about antipsychotic prescription patterns among children and adolescents in Japan, particularly in outpatient settings. We investigated the prevalence and trends of antipsychotic prescription for outpatients aged ≤ 17 years receiving a first antipsychotic prescription from 2006 to 2012 based on a large-scale dispensation dataset. Measurements included age, sex, department of diagnosis and treatment, type of prescription (monotherapy or polytherapy), antipsychotic dosage, and concomitant psychotropic drugs. Of the 10,511 patients, 65.1% were aged 13-17 years, and 52.9% were males. Second-generation antipsychotic monotherapy prescriptions increased from 53.8% in 2006 to 78.3% in 2012. Risperidone was the most frequently prescribed antipsychotic, followed by aripiprazole and olanzapine. Approximately 25.0% of patients were prescribed an initial dose less than recommended. Second-generation antipsychotic monotherapy is currently the most frequent prescription pattern among outpatients aged ≤ 17 years receiving an initial antipsychotic prescription.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy / Antipsychotic Agents Type of study: Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Child Psychiatry Hum Dev Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy / Antipsychotic Agents Type of study: Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Child Psychiatry Hum Dev Year: 2023 Document type: Article